Akintola: Faith Leaders Key in West Africa Ebola Fight, Urges Trust and Funding for DRC

In a column for The Guardian, Kayode Akintola argues that containing the escalating Bundibugyo Ebola outbreak in eastern Democratic Republic of the Congo requires the same community trust built by local faith leaders during the 2013–2016 West Africa crisis, alongside a reversal of drastic aid cuts.

The outbreak in eastern DRC is the country’s 17th and already its deadliest, with more than 5,000 deaths reported, The Guardian reported. The United Nations warns that viral spread is outpacing the international response, projecting up to 12 months to bring the surge under control if funding materializes.

Unlike the Zaire ebolavirus species targeted by licensed vaccines such as Ervebo, the circulating Bundibugyo variant lacks a proven vaccine or specific antiviral treatment, contributing to a case fatality rate approaching 50 percent among confirmed infections.

Akintola, the Africa head for the Catholic Agency for Overseas Development (Cafod) based in Lagos, draws a direct parallel to his experience as country director in Sierra Leone and Liberia during the West Africa epidemic. That outbreak recorded 28,600 cases and 11,300 deaths, with a case fatality rate near 40 percent, according to the U.S. Centers for Disease Control and Prevention.

“It was clear that age-old burial customs had to change, but people weren’t listening to directives from remote officialdom. It took members of their own communities, whom they knew and trusted, to change minds.”

Akintola told The Guardian.

Akintola: Faith Leaders Key in West Africa Ebola Fight, Urges Trust and Funding for DRC
Photo: newskenya.net

During the West Africa response, Catholic priests and Muslim imams used scriptural references to sanction safe and dignified burial protocols, replacing resistance with cooperation. Anonymous burial teams in full personal protective equipment (PPE) had initially fueled terror, driving families to hide the sick and conduct secret burials, which amplified transmission chains.

Akintola writes that he managed burial teams and trained volunteers in Sierra Leone, once isolating himself from his own daughters for four days over a potential exposure scare.

Bundibugyo Ebola Lacks Vaccine; Safe Burials Need Community Trust

  • The current Ebola outbreak in eastern DRC is caused by the Bundibugyo species, for which no licensed vaccine or curative antiviral exists, unlike the Zaire species covered by current stockpiles.
  • Safe burial practices remain the single most effective non-pharmaceutical intervention to break transmission, but they fail without community ownership.
  • Local faith leaders — imams, priests, traditional healers — are essential “trusted messengers” who can translate biomedical protocols into culturally acceptable actions.

Epidemiological Divergence: Bundibugyo vs. Zaire Species

The clinical urgency in eastern DRC stems from viral taxonomy. The 2013–2016 epidemic and the 2018–2020 Kivu outbreak were driven by Zaire ebolavirus, the target of the recombinant vesicular stomatitis virus–vectored vaccine (rVSV-ZEBOV, branded Ervebo) approved by the U.S. Food and Drug Administration and the European Medicines Agency.

The current surge involves Bundibugyo ebolavirus, a distinct species with roughly 30–50 percent case fatality in historical outbreaks. Cross-protective efficacy of the Zaire vaccine against Bundibugyo has not been established in clinical trials, leaving frontline workers and contacts without pharmacological prophylaxis.

Transmission dynamics remain identical: direct contact with blood, secretions, organs, or other bodily fluids of infected people, and with surfaces and materials contaminated with these fluids. The incubation period ranges from 2 to 21 days. In the absence of a vaccine, the World Health Organization (WHO) relies on ring vaccination strategies using investigational products under compassionate use protocols, alongside rigorous contact tracing and infection prevention and control (IPC) in health facilities.

Aid Cuts Drive Outbreak Severity; Conflict Zones Inflate Response Costs

Akintola identifies the “drastic cut in aid between the last decade and this one” as the primary driver of the current virulence. Medical institutions and charities are racing to build, staff, and equip treatment and isolation centers, but the UN financial tracking service shows the response plan remains significantly underfunded compared to the 2014–2016 appeal.

The conflict-affected terrain of North Kivu and Ituri provinces compounds logistical costs — cold chain maintenance for investigational vaccines, secure transport for samples, and hazard pay for staff — diverting resources from community engagement.

Attacks on clinics and burial teams, noted by Akintola, reflect a trust deficit exacerbated by decades of instability.

Health workers who survive infection or violence often face stigma upon return to their communities, further depleting the local workforce. The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has emphasized that community engagement is not ancillary but a core pillar of outbreak control, equivalent in weight to surveillance and case management.

Parameter West Africa 2013–2016 (Zaire ebolavirus) Eastern DRC Current (Bundibugyo ebolavirus)
Reported Cases 28,600 Data pending; deaths >5,000
Reported Deaths 11,300 >5,000
Case Fatality Rate ~40% ~50%
Key Community Lever Faith leaders (Cafod network) Faith leaders (proposed scale-up)

Health Workers Need Evaluation After Exposure; Residents with Symptoms Must Isolate

There are no medical contraindications to community engagement or safe burial protocols. However, clinical vigilance is required for:

Catholic Agency for Overseas Development traces its roots to a 1960 Family Fast Day organised by Catholic women to fund a mother-and-baby clinic in Dominica; the Bishops’ Conference of England and Wales registered it as a charity in 1962.

It is the official aid agency of the Catholic Church in England and Wales and operates as part of the Caritas Internationalis confederation. In 2023 it employed 391 staff and worked with more than 3,000 volunteers, channelling £41.8 million in grants to local partners across 42 countries and reaching one million vulnerable people directly.

  • Healthcare workers: Any percutaneous or mucous membrane exposure to blood or body fluids from a suspected Ebola patient warrants immediate occupational health evaluation and potential enrollment in investigational post-exposure prophylaxis protocols.
  • Community members: Sudden onset of fever, fatigue, muscle pain, headache, or sore throat in a resident of or traveler from an affected health zone within the past 21 days requires immediate isolation and alerting of local surveillance teams. Do not attempt home care.
  • Burial teams: Breaches in PPE integrity (tears, doffing errors) mandate immediate decontamination and 21-day symptom monitoring.

Akintola said the lesson of West Africa is that faith-based organisations have a role to play, adding that tackling Ebola is not just a medical problem.

References

  • World Health Organization. Ebola virus disease: Bundibugyo ebolavirus. WHO Fact Sheets.
  • U.S. Food and Drug Administration. Ervebo (rVSV-ZEBOV) Prescribing Information. FDA Approved Label.
  • World Health Organization. Strategic Advisory Group of Experts (SAGE) Recommendations on Ebola Vaccines. Weekly Epidemiological Record.
Photo of author

Health Desk

Health Desk at Archyde.

Kansas City Metro Holiday Season Set to Open With Tree Lightings, Displays